µ¿¹°¿ë Ç×»ýÁ¦ ½ÃÀå : ¾àÁ¦ À¯Çüº°, Á¦Çüº°, µ¿¹° À¯Çüº°, Áö¿ªº°
Veterinary Antibiotics Market, By Drug Type, By Dosage Form, By Animal Type, By Geography
»óǰÄÚµå : 1672922
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹°¿ë Ç×»ýÁ¦ ¼¼°è ½ÃÀåÀº 2025³â¿¡´Â 41¾ï 8,000¸¸ ´Þ·¯, 2032³â¿¡´Â 55¾ï 1,000¸¸ ´Þ·¯¿¡ À̸£°í, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 4.0%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 41¾ï 8,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 4.00% 2032³â °¡Ä¡ ¿¹Ãø 55¾ï 1,000¸¸ ´Þ·¯
±×¸². µ¿¹°¿ë Ç×»ýÁ¦ ½ÃÀå Á¡À¯À²(%), 2025³â Áö¿ªº°
Veterinary Antibiotics Market-IMG1

µ¿¹°¿ë Ç×»ýÁ¦ ½ÃÀåÀº µ¿¹° °Ç°­ °ü¸® ÁöÃâ Áõ°¡¿Í Àηù °øÅë °¨¿°ÀÇ ¸¸¿¬À¸·Î ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ƯÈ÷ ¼±ÁøÁö¿ª¿¡ À־ÀÇ µ¿¹° »çÀ°ÀÇ °³¹ßÀÌ, ¹Ý·Áµ¿¹°ÀÇ ´Ù¾çÇÑ °¨¿°ÁõÀ» ¿¹¹æ ¹× Ä¡·áÇÏ´Â Ç×»ý¹°Áú ¼ö¿ä¸¦ ²ø¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡, ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­¿Í µ¿¹° À¯·¡ÀÇ ´Ü¹éÁúÀÌ Ç³ºÎÇÑ ½Ä»ç¿¡ ´ëÇÑ ÁÖ¸ñÀÇ °íÁ¶°¡, ¼¼°è¿¡¼­ À°·ù »ý»êÀ» Ȱ¼ºÈ­Çϰí ÀÖ½À´Ï´Ù. ´ë±Ô¸ð °¡Ãà »ý»ê¿¡´Â ½ÄÀ°¿ëÀ¸·Î »çÀ°µÇ´Â µ¿¹°ÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí Áúº´À» ¿¹¹æÇϱâ À§ÇØ Ç×»ýÁ¦ÀÇ ÀûÀýÇÑ »ç¿ëÀÌ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

°¡Ãà À¯·¡ ½Äǰ ¼Òºñ Áõ°¡´Â µ¿¹° Ç×»ýÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼Ó½Ãų ¼ö ÀÖ½À´Ï´Ù. 2019³â À¯¿£ ½Ä·®³ó¾÷±â°ü¿¡ µû¸£¸é ¼¼°è ½ÄÀ° »ý»ê·®Àº 2020³âºÎÅÍ 2030³â »çÀÌ¿¡ ¾à 15% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±×·¯³ª Ãà»ê ºÐ¾ß¿¡¼­ Ç×»ýÁ¦¸¦ °úµµÇÏ°Ô »ç¿ëÇϰųª ¿À¿ëÇϸé Ç×»ýÁ¦ ³»¼ºÀ» À¯¹ßÇÏ¿© ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÕ´Ï´Ù. ¹ÚÅ׸®¿ÀÆÄÁö ¹× ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ Æ÷ÇÔÇÑ ´ëü Ä¡·á ¿É¼ÇÀº ½ÃÀå °ü°èÀÚ¿¡°Ô Å« ±âȸÀÔ´Ï´Ù. °³¹ß µµ»ó±¹¿¡¼­ ¼öÀÇÇÐ °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ °³¹ßÀº °¡±î¿î ¹Ì·¡¿¡ Ç×»ýÁ¦ Á¦Á¶¾÷ü¿¡ »õ·Î¿î ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

º» º¸°í¼­´Â ¼¼°è µ¿¹°¿ë Ç×»ýÁ¦ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2024³âÀ» ±âÁØ¿¬µµÀ¸·Î ÇÑ ¿¹Ãø±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í º¹ÇÕ¿¬°£ ¼ºÀå·ü(CAGR%)À» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.

¼¼°è µ¿¹°¿ë Ç×»ýÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷Àº Merck&Co., Inc., Ceva Sante Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac SA, Bimeda, Inc., Vetoquinol, Zydus Animal Health ealth Corporation µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂûÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

µ¿¹° Ç×»ýÁ¦ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µîÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¸¦ ´Ù·ì´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è µ¿¹°¿ë Ç×»ýÁ¦ ½ÃÀåÀ» ºÐ¼®Çϴµ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå µ¿¹°¿ë Ç×»ý¹°Áú ½ÃÀå, ¾àÁ¦ À¯Çüº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦5Àå µ¿¹°¿ë Ç×»ý¹°Áú ½ÃÀå, Á¦Çüº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦6Àå µ¿¹°¿ë Ç×»ý¹°Áú ½ÃÀå, µ¿¹° À¯Çüº°, 2020³â-2032³â(10¾ï ´Þ·¯)

Á¦7Àå µ¿¹°¿ë Ç×»ý¹°Áú ½ÃÀå, Áö¿ªº°, 2020³â-2032³â,(10¾ï ´Þ·¯)

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ºÐ¼®°¡ Ãßõ

Á¦10Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Veterinary Antibiotics Market is estimated to be valued at USD 4.18 Bn in 2025 and is expected to reach USD 5.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.18 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.00% 2032 Value Projection: USD 5.51 Bn
Figure. Veterinary Antibiotics Market Share (%), By Region 2025
Veterinary Antibiotics Market - IMG1

Veterinary antibiotics market has witnessed significant growth due to rising animal healthcare expenditure and increasing prevalence of zoonotic diseases. Growing animal adoption, particularly in developed regions, has also boosted demand for antibiotics to prevent and treat various infections in companion animals. Moreover, changing lifestyles and increasing focus on protein-rich diets from animal sources have revved up meat production across the globe. Large scale livestock production practices necessitate the proper use of antibiotics to promote growth and prevent diseases in animals reared for meat consumption.

Market Dynamics

Rising consumption of livestock-derived food products can drive the veterinary antibiotics market growth. In 2019, according to the United Nations Food and Agriculture Organization, global meat production is projected to grow approximately 15% in the period between 2020 and 2030. However, overuse and misuse of antibiotics in the livestock sector has led to antibiotic resistance, thus, hampering the market growth. Alternative treatment options including bacteriophages and probiotics present significant opportunities for market players. Growing veterinary healthcare infrastructure in developing nations can create new avenues for antibiotics manufacturers in the near future.

Key features of the study

This report provides in-depth analysis of the global veterinary antibiotics market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global veterinary antibiotics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Merck & Co., Inc., Ceva Sante Animale, Zoetis, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals, Elanco Animal Health Incorporated, Virbac S.A., Bimeda, Inc., Vetoquinol, Zydus Animal Health, Blacksmith Medicines, Inovet, Calier, and Phibro Animal Health Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global veterinary antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary antibiotics market

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Veterinary Antibiotics Market, By Drug Type, 2020-2032, (USD Bn)

5. Veterinary Antibiotics Market, By Dosage Form, 2020-2032, (USD Bn)

6. Veterinary Antibiotics Market, By Animal Type, 2020-2032, (USD Bn)

7. Veterinary Antibiotics Market, By Region, 2020 - 2032, (USD Bn)

8. Competitive Landscape

9. Analyst Recommendations

10. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â